Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-20 of 20 for your search:
Cancer Type/Condition:
Non-Hodgkin lymphoma, child
Stage/Subtype:
stage I childhood large cell lymphoma
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Mature B-Cell Lymphoma And Leukemia Study III
Phase:
Phase III, Phase II
Type:
Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status:
Active
Age:
0 to 21
Sponsor:
Other
Protocol IDs:
SJBC3
, NCT01046825
2.
Phase III Randomized Study of Glutamic Acid in Reducing Vincristine-Related Peripheral Neurotoxicity in Young Patients Undergoing Vincristine-Containing Treatment for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
3 to 20
Sponsor:
NCI
Protocol IDs:
HLMCC-0402
, NCT00369564, ACCL 0731
3.
Phase I/II Study of Epstein Barr Virus Specific Cytotoxic T Lymphocytes from a Normal HLA-Compatible Donor in the Treatment of Patients With Epstein Barr Virus Associated Lymphomas and Other Lymphoproliferative Diseases or Malignancies
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
MSKCC-95024
, NCI-V95-0685, NCT00002663
4.
Phase I/II Study of Reduced-Intensity Preparative Regimen Comprising Fludarabine, Busulfan, and Alemtuzumab Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies or Other Diseases
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
70 and under
Sponsor:
Other
Protocol IDs:
BCM-H-19386
, BCM-FAB, H 19386, NCT00625144
5.
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
0 to 55
Sponsor:
Other
Protocol IDs:
8717
, NCT00673114
6.
Phase II Study of Myeloablative Preparative Regimen Comprising Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Patients Undergoing Unrelated Umbilical Cord Blood Transplantation for Hematologic Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
45 and under
Sponsor:
NCI
Protocol IDs:
UMN-2005LS043
, UMN-BMT-MT2005-10, UMN-MT2005-10, UMN-0507M71475, NCT00309842
7.
Phase II Study of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin's or Hodgkin's Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 70
Sponsor:
NCI
Protocol IDs:
UMN-2005LS048
, UMN-0508M72589, UMN-MT2004-24, NCT00345865
8.
Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 to 60
Sponsor:
Other
Protocol IDs:
2005-0054
, NCT00290498
9.
Phase II Study of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer or Other Diseases
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
70 years old and under
Sponsor:
NCI
Protocol IDs:
CCCWFU-29506
, CCCWFU 29506, NCT00453206, CCCWFU-IRB00001366
10.
Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
CINJ-3330
, NCT00161187
11.
Phase II Study of Unrelated Umbilical Cord Blood Transplantation in Combination With a Myeloablative Preparative Regimen Comprising Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Patients With Hematological Diseases
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
6 months to 45 years
Sponsor:
NCI
Protocol IDs:
FHCRC-2010.00
, 6095, NCT00719888
12.
Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0604)
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
1 to 70
Sponsor:
NCI, NHLBI
Protocol IDs:
606
, U01 HL069294, NCT00864227
13.
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
3 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
P2 L-D AB
, NCT00917826
14.
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
0 to 65
Sponsor:
Other
Protocol IDs:
2009-0266
, NCT01010217
15.
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
0 to 26
Sponsor:
Other
Protocol IDs:
CHNY 525
, AAAB2879, NCT01049854
16.
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
0 to 55
Sponsor:
Other
Protocol IDs:
CHNY-02-516
, IRB# AAAB3095, NCT01050439
17.
Phase I Pilot Study of Myeloablative Conditioning Comprising Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Ex Vivo-Expanded Umbilical Cord Blood Progenitors and Unmanipulated Umbilical Cord Blood Transplantation and Immunosuppression Comprising Cyclosporine and Mycophenolate Mofetil in Patients With Hematologic Cancer and Other Diseases
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
6 months to 45 years
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
FHCRC-2044.00
, AMGEN-200981, NCT00343798
18.
Phase I Study of Autologous or Allogeneic LMP-Specific Cytotoxic T-Lymphocytes in Patients With Epstein-Barr Virus (EBV)-Positive Lymphoma, Lymphoepithelioma, or Severe Chronic Active EBV Infection Syndrome
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
BCM-H-9936-ALCI
, H 9936, NCT00671164
19.
Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
22899
, NCT00709033
20.
Infusion of Myeloid Progenitors to Speed Neutrophil Recovery After Umbilical Cord Blood Transplant in Patients With Hematologic Malignancy
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
12 to 45
Sponsor:
NCI, Other
Protocol IDs:
CDR0000640542
, UMN-MT2008-38, UMN-2008LS139, CELLERANT-MT2008-38, UMN-0812M56066, NCT00891137
Select All on Page
Help with Results
